Citi Appointed as Depositary Bank for Vicore Pharma Holding AB’s ADR Program

Key Terms

depositary bank financial

A depositary bank is a financial institution that holds and safeguards a company's or investor’s securities, such as stocks or bonds, in a secure account. It acts like a digital safe, ensuring that ownership records are accurate and that transactions are processed smoothly. For investors, it provides confidence that their investments are protected and correctly recorded, making buying, selling, or transferring securities reliable and efficient.

american depositary receipt financial

An American depositary receipt (ADR) is a certificate that represents shares of a foreign company traded on U.S. stock exchanges. It allows investors to buy and sell parts of a foreign company's stock easily, much like purchasing shares of a company based in their own country. ADRs make international investing more convenient and accessible for U.S. investors.

adr program financial

An ADR Program is the legal structure between a foreign company and a US depositary bank for issuing American Depositary Receipts. It defines the program level (I, II, III), ADS ratio, fees, and SEC reporting requirements. Levels determine whether shares can list on exchanges or only OTC.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LONDON--(BUSINESS WIRE)-- Citi Issuer Services, acting through Citibank N.A., has been appointed by Vicore Pharma Holding AB (“Vicore Pharma”), a clinical-stage biopharmaceutical company unlocking the potential of a new class of drugs with disease-modifying potential in respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF), to act as Depositary Bank for its sponsored Level 2 American Depositary Receipt (“ADR”) program.

Vicore Pharma’s ADRs trade on the Nasdaq Capital Market under the symbol “VCRE”. Each ADS represents ten ordinary shares of the company. Vicore Pharma’s underlying ordinary shares are listed and traded on the Nasdaq Stockholm Stock Exchange under the symbol “VICO”.

Commenting on the appointment, Dirk Jones, Head of Issuer Services at Citi, said: “We are committed to supporting Vicore Pharma with high quality services through our industry-leading ADR solutions. Our deep capital markets expertise and extensive global network enable us to facilitate seamless access to global capital markets for issuers like Vicore Pharma.”

Citi Issuer Services is a leading provider of depositary receipt services. With depositary receipt programs in over 65 markets, spanning equity and fixed-income products, Issuer Services leverages Citi’s global network to provide cross-border capital market access to issuers, intermediaries, and investors.

About Citi

Citi is a preeminent banking partner for institutions with cross-border needs, a global leader in wealth management and a valued personal bank in its home market of the United States. Citi does business in more than 180 countries and jurisdictions, providing corporations, governments, investors, institutions and individuals with a broad range of financial products and services.

Additional information may be found at www.citigroup.com | X: @Citi | LinkedIn: www.linkedin.com/company/citi | YouTube: www.youtube.com/citi | Facebook: www.facebook.com/citi

View source version on businesswire.com: https://www.businesswire.com/news/home/20260706927822/en/

Citi Media Contact:
Harsha Jethnani
harsha.jethnani@citi.com
+65 93830872

Source: Citigroup Inc.